One of the most explored targets in the field of fluorescence-guided surgery is the epidermal growth factor receptor (EGFR), as it is overexpressed in several types of cancer, including breast, lung, bladder, brain, and head and neck cancer (Talukdar et al., 2020). This evidence concerns the gene EGFR and cancer.